Literature DB >> 10668431

Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury.

S K Ray1, G G Wilford, D C Matzelle, E L Hogan, N L Banik.   

Abstract

Intracellular free Ca2+ and free radicals are increased following spinal cord injury (SCI). These can activate calpain to degrade cytoskeletal proteins leading to apoptotic and necrotic cell death. Primary injury triggers a cascade of secondary injury, which spreads to rostral and caudal areas. We tested calpain involvement in apoptosis in five 1-cm segments of rat spinal cord with injury (40 g-cm) induced at T12 by weight-drop. Animals were immediately treated with calpeptin (250 micrograms/kg) and methylprednisolone (165 mg/kg) and sacrificed at 48 hr. Untreated SCI rats manifested 68-kD neurofilament protein (NFP) degradation (indicating calpain activity), and internucleosomal DNA fragmentation (indicating apoptosis). Both calpain activity and apoptosis were highest in the lesion, and decreased with increasing distance from the lesion. Treatment decreased 68-kD NFP degradation with reduction in apoptosis in all five areas. Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668431     DOI: 10.1111/j.1749-6632.1999.tb08001.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

1.  Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury.

Authors:  Chen-Guang Yu; James W Geddes
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

Review 2.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

3.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

4.  Neuroprotective Effect of Calpeptin on Acrylamide-Induced Neuropathy in Rats.

Authors:  Xiaomin Wei; Fengfeng Yan; Meng E; Cuili Zhang; Guozhen Li; Xiwei Yang; Fengmei Zhang; Shue Wang; Sufang Yu
Journal:  Neurochem Res       Date:  2015-09-30       Impact factor: 3.996

5.  Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent.

Authors:  Jonathan D Moore; Nancy J Rothwell; Rosemary M Gibson
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 6.  Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers.

Authors:  Abhay K Varma; Arabinda Das; Gerald Wallace; John Barry; Alexey A Vertegel; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2013-03-06       Impact factor: 3.996

7.  Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-gamma.

Authors:  Joshua A Smith; Ran Zhang; Abhay K Varma; Arabinda Das; Swapan K Ray; Naren L Banik
Journal:  Brain Res       Date:  2009-09-11       Impact factor: 3.252

Review 8.  Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury.

Authors:  Shushi Kabu; Yue Gao; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2015-09-04       Impact factor: 9.776

Review 9.  Recent advances in the pharmacologic treatment of spinal cord injury.

Authors:  April Cox; Abhay Varma; Naren Banik
Journal:  Metab Brain Dis       Date:  2014-05-16       Impact factor: 3.584

10.  Influences of HIF-lα on Bax/Bcl-2 and VEGF expressions in rats with spinal cord injury.

Authors:  Mao-Hua Chen; Qing-Xian Ren; Wen-Fa Yang; Xiang-Lin Chen; Chuan Lu; Jun Sun
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.